BACKGROUND: Although differences between black and white persons in hemoglobin A(1c) (HbA(1c)) values are well established, recent studies suggest that this might not reflect differences in glycemia. OBJECTIVE: To investigate racial disparities in glycemic markers, including those that reflect biological processes independent of hemoglobin glycation and erythrocyte turnover. DESIGN: Cross-sectional. SETTING: Community-based. PARTICIPANTS: 1376 nondiabetic and 343 diabetic adults in a substudy of the Atherosclerosis Risk in Communities Study. MEASUREMENTS: Hemoglobin A(1c), fasting glucose, glycated albumin, fructosamine, and 1,5-anhydroglucitol levels. RESULTS: Among persons with and without diabetes, black persons had significantly higher HbA(1c), glycated albumin, and fructosamine levels than white persons before and after adjustment for covariates and fasting glucose concentration. Serum 1,5-anhydroglucitol levels, which are reduced in the setting of hyperglycemia-induced glycosuria, were lower in black persons than in white persons, although this difference was statistically significant only in nondiabetic adults. LIMITATION: The design was cross-sectional, a limited number of participants with a history of diabetes was included, and the study did not include integrated measures of circulating nonfasting glycemia. CONCLUSION: Differences between black and white persons in glycated albumin, fructosamine, and 1,5-anhydroglucitol levels parallel differences between these groups in HbA(1c) values. Racial differences in hemoglobin glycation and erythrocyte turnover cannot explain racial disparities in these serum markers. The possibility that black persons have systematically higher levels of nonfasting glycemia warrants further study. PRIMARY FUNDING SOURCE: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
BACKGROUND: Although differences between black and white persons in hemoglobin A(1c) (HbA(1c)) values are well established, recent studies suggest that this might not reflect differences in glycemia. OBJECTIVE: To investigate racial disparities in glycemic markers, including those that reflect biological processes independent of hemoglobin glycation and erythrocyte turnover. DESIGN: Cross-sectional. SETTING: Community-based. PARTICIPANTS: 1376 nondiabetic and 343 diabetic adults in a substudy of the Atherosclerosis Risk in Communities Study. MEASUREMENTS: Hemoglobin A(1c), fasting glucose, glycated albumin, fructosamine, and 1,5-anhydroglucitol levels. RESULTS: Among persons with and without diabetes, black persons had significantly higher HbA(1c), glycated albumin, and fructosamine levels than white persons before and after adjustment for covariates and fasting glucose concentration. Serum 1,5-anhydroglucitol levels, which are reduced in the setting of hyperglycemia-induced glycosuria, were lower in black persons than in white persons, although this difference was statistically significant only in nondiabetic adults. LIMITATION: The design was cross-sectional, a limited number of participants with a history of diabetes was included, and the study did not include integrated measures of circulating nonfasting glycemia. CONCLUSION: Differences between black and white persons in glycated albumin, fructosamine, and 1,5-anhydroglucitol levels parallel differences between these groups in HbA(1c) values. Racial differences in hemoglobin glycation and erythrocyte turnover cannot explain racial disparities in these serum markers. The possibility that black persons have systematically higher levels of nonfasting glycemia warrants further study. PRIMARY FUNDING SOURCE: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
Authors: G Viberti; J Lachin; R Holman; B Zinman; S Haffner; B Kravitz; M A Heise; N P Jones; M C O'Neill; M I Freed; S E Kahn; W H Herman Journal: Diabet Med Date: 2006-12 Impact factor: 4.359
Authors: Julienne K Kirk; Leah V Passmore; Ronny A Bell; K M Venkat Narayan; Ralph B D'Agostino; Thomas A Arcury; Sara A Quandt Journal: Diabetes Care Date: 2007-10-31 Impact factor: 19.112
Authors: Arleen F Brown; Edward W Gregg; Mark R Stevens; Andrew J Karter; Morris Weinberger; Monika M Safford; Tiffany L Gary; Dorothy A Caputo; Beth Waitzfelder; Catherine Kim; Gloria L Beckles Journal: Diabetes Care Date: 2005-12 Impact factor: 19.112
Authors: Julienne K Kirk; Ralph B D'Agostino; Ronny A Bell; Leah V Passmore; Denise E Bonds; Andrew J Karter; K M Venkat Narayan Journal: Diabetes Care Date: 2006-09 Impact factor: 19.112
Authors: Mary K Rhee; Curtiss B Cook; Virginia G Dunbar; Rita M Panayioto; Kathy J Berkowitz; Barbara Boyd; Christopher D George; Robert H Lyles; Imad M El-Kebbi; Lawrence S Phillips Journal: J Health Care Poor Underserved Date: 2005-11
Authors: William H Herman; Yong Ma; Gabriel Uwaifo; Steven Haffner; Steven E Kahn; Edward S Horton; John M Lachin; Maria G Montez; Tina Brenneman; Elizabeth Barrett-Connor Journal: Diabetes Care Date: 2007-05-29 Impact factor: 19.112
Authors: Christina M Parrinello; A Richey Sharrett; Nisa M Maruthur; Richard M Bergenstal; Morgan E Grams; Josef Coresh; Elizabeth Selvin Journal: Diabetes Care Date: 2015-12-17 Impact factor: 19.112
Authors: N Furusyo; T Koga; M Ai; S Otokozawa; T Kohzuma; H Ikezaki; E J Schaefer; J Hayashi Journal: Diabetologia Date: 2011-09-27 Impact factor: 10.122
Authors: Sherita Hill Golden; Arleen Brown; Jane A Cauley; Marshall H Chin; Tiffany L Gary-Webb; Catherine Kim; Julie Ann Sosa; Anne E Sumner; Blair Anton Journal: J Clin Endocrinol Metab Date: 2012-06-22 Impact factor: 5.958
Authors: Laurence Slama; Frank J Palella; Alison G Abraham; Xiuhong Li; Corinne Vigouroux; Gilles Pialoux; Lawrence Kingsley; Jordan E Lake; Todd T Brown Journal: J Antimicrob Chemother Date: 2014-08-04 Impact factor: 5.790
Authors: Rita Rastogi Kalyani; Nan Ji; Mercedes Carnethon; Alain G Bertoni; Elizabeth Selvin; Edward W Gregg; Mario Sims; Sherita Hill Golden Journal: J Diabetes Complications Date: 2017-03-09 Impact factor: 2.852